Академический Документы
Профессиональный Документы
Культура Документы
Clinical
Toxicology
of Caffeine
A Review and case study
ABSTRACT
Caffeine (1,3,7-trimethylxanthine) is a
psychostimulant purine-like alkaloid
Absorption
• Caffeine has rapid and complete absorption from the small intestine
after oral administration in humans due to its weakly basic nature
and pKa of 14 at 25°C lipophilic state in the more basic environment
of the small intestine where it may more easily partition into the
lipid bilayer of cells, as compared to the acidic environment of the
stomach where it is more ionized and less lipophilic
• Lipophilic state in the more basic environment of the small intestine
where it may more easily partition into the lipid bilayer of cells, as
compared to the acidic environment of the stomach where it is
more ionized and less lipophilic
Distribution
• Caffeine is distributed throughout the body after
being absorbed from the gastrointestinal tract,
entering all tissues via cell membranes and
entering intracellular tissue water
• Penetrates the blood-brain barrier as well
Metabolism
• Caffeine is primarily metabolized to 1,7-
dimethylxanthine (paraxanthine) in the liver via the
CYP isozyme CYP1A2, which causes 3-
demethylation of caffeine
Elimination
• Elimination occurs mainly via renal excretion in urine
(∼85–88%),
• Fecal excretion also takes place to a limited extent
(i.e.,around 2–5%)
Toxicokinetics
• Above concentrations of 15 mg/L is considered
Toxicological symptoms
• Concentration of 50 mg/L is considered “toxic”
• Concentrations of 80 mg/L or greater are considered
lethal
Mechanism of action
• Caffeine interact with Adenosine receptors
• Caffeine activates Calcium intracellular release
channel from skeletal muscle, cardiac muscle and
neuronal tissue
• Caffeine is also known to increase catecholamine
levels which can explain at least some of its
physiological effects
• Caffeine has cholinergic effects as it has been shown
to inhibit acetylcholinesterase with a Ki of 175 μmol
a concentration that is in cases of intoxication
MANAGEMENT AND
TREATMENT
SIDE EFFECT TREATMENT
Cardiovascular side effects
• Hypotension Isotonic intravenous fluid
• Supraventricular tachycardia (SVT) Benzodiazepin
Gastrointestinal side effects
• Vomiting Anti emetic
Psychological side effects and seizures
• Agitation, anxiety and seizures Benzodiazepin
Barbiturate
Metabolic side effects and rhabdomyolysis
• Metabolic acidosis and Intravenous fluid
hypokalemia Sodium bicarbonate
Decontamination and enhanced Activated carbon
elimination
CONCLUSION
FK UMY 2013